| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 120.30B | 113.47B | 103.72B | 97.38B | 94.45B |
| Gross Profit | 30.35B | 29.11B | 24.48B | 21.96B | 24.00B |
| EBITDA | 13.09B | 13.11B | 9.26B | 6.45B | 9.24B |
| Net Income | 5.91B | 5.57B | 3.07B | 1.10B | 3.37B |
Balance Sheet | |||||
| Total Assets | 101.41B | 95.84B | 94.23B | 87.63B | 83.26B |
| Cash, Cash Equivalents and Short-Term Investments | 20.84B | 17.39B | 19.59B | 16.18B | 16.79B |
| Total Debt | 3.67B | 3.69B | 5.34B | 5.75B | 1.07B |
| Total Liabilities | 34.20B | 34.34B | 37.80B | 34.09B | 30.47B |
| Stockholders Equity | 67.21B | 61.49B | 56.43B | 53.54B | 52.79B |
Cash Flow | |||||
| Free Cash Flow | 5.17B | -294.00M | 4.46B | -3.60B | 3.18B |
| Operating Cash Flow | 9.28B | 6.53B | 9.81B | 2.12B | 8.09B |
| Investing Cash Flow | -4.37B | -6.47B | -5.29B | -6.74B | -5.12B |
| Financing Cash Flow | -1.51B | -2.23B | -1.18B | 3.97B | -1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥53.40B | 13.94 | ― | 1.51% | 5.26% | 16.22% | |
76 Outperform | ¥220.47B | 12.35 | 13.33% | 3.47% | 3.47% | 40.18% | |
73 Outperform | ¥69.19B | 7.81 | ― | 1.55% | 6.02% | 5.87% | |
72 Outperform | ¥30.59B | 10.02 | ― | 1.23% | 4.84% | 6.19% | |
69 Neutral | ¥53.50B | 12.53 | ― | 4.63% | 8.98% | 2.01% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ¥62.27B | 513.85 | ― | 1.14% | 9.13% | -21.27% |